126 related articles for article (PubMed ID: 4727362)
1. The synthesis and xanthine oxidase inhibitory activity of pyrazolo(3,4-d)pyrimidines.
Kobayashi S
Chem Pharm Bull (Tokyo); 1973 May; 21(5):941-51. PubMed ID: 4727362
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of xanthine oxidase inhibitors. Pyrazolo(3,4-d)pyrimidines and pyrazolo(3,4-b)pyridines.
Chu I; Lynch BM
J Med Chem; 1975 Feb; 18(2):161-5. PubMed ID: 1120982
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines.
Springer RH; Dimmitt MK; Novinson T; O'Brien DE; Robins RK; Simon LN; Miller JP
J Med Chem; 1976 Feb; 19(2):291-6. PubMed ID: 2778
[TBL] [Abstract][Full Text] [Related]
4.
Malik N; Dhiman P; Khatkar A
Curr Drug Targets; 2019; 20(5):593-603. PubMed ID: 30465499
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors.
Ali HI; Fujita T; Akaho E; Nagamatsu T
J Comput Aided Mol Des; 2010 Jan; 24(1):57-75. PubMed ID: 20039101
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of antiuric action of 4-oxy- and 4-thiopyrazolopyrimidines.
Cartier PH; Hamet M
Biochem Pharmacol; 1973 Dec; 22(23):3061-75. PubMed ID: 4761565
[No Abstract] [Full Text] [Related]
9. Stoichiometric inhibition of reduced xanthine oxidase by hydroxypyrazolo [3,4-d]pyrimidines.
Spector T; Johns DG
J Biol Chem; 1970 Oct; 245(19):5079-85. PubMed ID: 5506275
[No Abstract] [Full Text] [Related]
10. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ferritin reduction by pyrazolo(3,4d)pyrimidines.
Duggan DE; Streeter KB
Arch Biochem Biophys; 1973 May; 156(1):66-70. PubMed ID: 4740962
[No Abstract] [Full Text] [Related]
13. Hydroxyakalone, a novel xanthine oxidase inhibitor produced by a marine bacterium, Agrobacterium aurantiacum.
Izumida H; Adachi K; Mihara A; Yasuzawa T; Sano H
J Antibiot (Tokyo); 1997 Nov; 50(11):916-8. PubMed ID: 9592563
[TBL] [Abstract][Full Text] [Related]
14. Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR).
Hubbard RD; Bamaung NY; Palazzo F; Zhang Q; Kovar P; Osterling DJ; Hu X; Wilsbacher JL; Johnson EF; Bouska J; Wang J; Bell RL; Davidsen SK; Sheppard GS
Bioorg Med Chem Lett; 2007 Oct; 17(19):5406-9. PubMed ID: 17689078
[TBL] [Abstract][Full Text] [Related]
15. The resolution of active and inactive xanthine oxidase by affinity chromatography.
Edmondson D; Massey V; Palmer G; Beacham LM; Elion GB
J Biol Chem; 1972 Mar; 247(5):1597-604. PubMed ID: 4335003
[No Abstract] [Full Text] [Related]
16. Behavior of N-methylated allopurinols and related 4-thioxopyrazolo [3,4-d]pyrimidines towards bovine milk xanthine oxidase.
Bergmann F; Frank A; Govrin H
Biochim Biophys Acta; 1979 Sep; 570(1):215-20. PubMed ID: 486504
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists.
Huang CQ; Wilcoxen KM; Grigoriadis DE; McCarthy JR; Chen C
Bioorg Med Chem Lett; 2004 Aug; 14(15):3943-7. PubMed ID: 15225703
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
[TBL] [Abstract][Full Text] [Related]
20. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL
Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
